Glutathione S-transferase M1,T1 and P1 polymorphisms: Susceptibility and outcome in lung cancer patients

Journal of Experimental Therapeutics and Oncology

Volumn 7, Issue 1, 2008, Pages 73-85

  Sreeja, Leelakumari ^a   Syamala, Vani ^a   Hariharan, Sreedharan ^a   Syamala, Volga S ^a   Raveendran, Praveenkumar B ^a   Sivanandan, C D ^a   Madhavan, Jayaprakash ^a   Ankathil, Ravindran ^a  

^a REGIONAL CANCER CENTRE   (India)

Author keywords

Glutathione S transferase M1 (GSTM1); GSTP1; GSTT1; Lung cancer; Polymorphism; Survival; Susceptibility

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; INCIDENCE; INDIA; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS;

EID: 42049091942     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Spivack SD, Fasco MJ, Walker VE, Kaminsky LS. The molecular epidemiology of lung cancer. Crit Rev Toxicol 27:319-365, 1997.
2. Raunio H, Husgafvel-Pursiainen K, Anttila S, Hietanen E. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility - a review. Gene 159:113-121, 1995.
3. Seidegard J, Pero RW, Miller DG, Beattie EJ.A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 7:751-753. 1986.
4. Pemble S, Schroeder KR, Spencer SR, Meyer DJ. Human glutathione S-transferase theta (GSTT1). cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300:271-276, 1994.
5. London SJ, Yuan JM, Chung FL, Gao YT. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung cancer risk: a prospective study of men in Shanghai, China. Lancet 356:724-9, 2000.
6. Ali-Osman F, Akande O, Antoun G, Mao JX. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 272:10004-10012, 1997.
7. Harries LW, Stubbins MJ, Forman D, Howard GC. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18:641-644, 1997.
8. Autrup H. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat Res 464:65-76, 2000.
9. Sreeja L, Syamala V, Hariharan S, Madhavan J, Devan SC, Ankathil R. Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J Hum Genet 50:618-627, 2005.
10. Sambrook J, Fritsch EFFrustaci , Maniatis T Molecular cloning. A laboratory manual. 2nd edition New York. Cold Spring Harbor Laboratory Press, 1989.
11. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 85: 1159-1164, 1993.
12. Chen H, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 347:295-297, 1996.
13. Curran JE, Weinstein S R, Griffiths LR. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility. Cancer Lett 53: 113-120, 2000.
14. Kato S, Bowman ED, Harrington AM, Blomeke B, Shields PG. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J Natl Cancer Inst 87:902-907, 1995.
15. Hirvonen A. Genetic factors in individual responses to environmental exposures. J Occup Environ Med 37:37-43, 1995.
16. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 6:733-743, 1997.
17. Houlston RS:. Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 8:675-682, 1999.
18. Vineis P:. The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology 181: 457-462, 2002.
19. Benhamou S, Lee WJ, Alexandrie AK, Boffetta P, Bouchardy C, Butkiewicz D. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 23:1343-50, 2002.
20. Nazar-Stewart V, Vaughan TL, Stapleton P, Van Loo J, Nicol-Blades B, Eaton DL. A population-based study of glutathione S-transferase M1, T1 and P1 genotypes and risk for lung cancer. Lung Cancer 40:247-258, 2003.
21. Sunaga N, Kohno T, Yanagitani N, Sugimura H, Kunitoh H, Tamura T. Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol Biomarkers Prev 11:730-738, 2002.
22. Sorensen M, Raaschou-Nielsen O, Brasch-Andersen C, Tjonneland A, Overvad K. Interactions between GSTM1, GSTT1 and GSTP1 polymorphisms and smoking and intake of fruit and vegetables in relation to lung cancer. Lung Cancer 55:137-144, 2007.
23. Hosgood HD, Berndt SI, Lan Q. GST genotypes and lung cancer susceptibility in Asian populations with indoor air pollution exposures: A meta-analysis. Mutat Res, 636: 134-43, 2007.
24. Raimondi S, Paracchini V, Autrup H, Barros-Dios JM, Benhamou S, Boffetta P, Cote ML, Dialyna IA, Dolzan V. Filiberti R, Garte S, Hirvonen A, Husgafvel-Pursiainen K, Imyanitov EN, Kalina I, Kang D, Kiyohara C, Kohno T, Kremers P, Lan Q, London S, Povey AC, Rannug A, Reszka E, Risch A, Romkes M, Schneider J, Seow A, Shields PG, Sobti RC, Sørensen M, Spinola M, Spitz MR, Strange RC, Stücker I, Sugimura H, To-Figueras J, Tokudorne S, Yang P, Yuan JM, Warholm M, Taioli E. Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol. 11:1027-42, 2006.
25. Taioli E, Gaspari L, Benhamou S, Boffetta P, Brockmoller J, Butkiewicz D. Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int J Epidemiol 32:60-63, 2003.
26. Lan Q, He X, Costa DJ, Tian L, Rothman N, Hu G.. Indoor coal combustion emissions, GSTM1 and GSTT1 genotypes, and lung cancer risk: a case-control study in Xuan Wei, China. Cancer Epidemiol Biomarkers Prev 9:605-608, 2000.
27. Ye Z, Song H, Higgins JP, Pharoah P, Danesh J. Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med 3: e91, 2006.
28. Naveen AT, Adithan C, Padmaja N, Shashindran CH, Abraham BK, Satyanarayanamoorthy K. Glutathione S-transferase M1 and T1 null genotype distribution in South Indians. Eur J Clin Pharmacol 60:403-406, 2004.
29. Mishra DK, Kumar A, Srivastava DS, Mittal RD: Allelic variation of GSTT1, GSTM1 and GSTP1 genes in North Indian population. Asian Pac J Cancer Prev 5:362-365, 2004.
30. Lewis SJ, Cherry NM, Niven RM, Barber PV, Povey AC:. GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk. Cancer Lett 180:165-171, 2002.
31. Miller DP, Neuberg D, de V, I, Wain JC, Lynch TJ, Su L. Smoking and the risk of lung cancer: susceptibility with GSTP1 polymorphisms. Epidemiology 14:545-551, 2003.
32. Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19:275-280, 1998.
33. Nazar-Stewart V, Vaughan TL, Stapleton P, Van Loo J, Nicol-Blades B, Eaton DL. A population-based study of glutathione S-transferase M1, T1 and P1 genotypes and risk for lung cancer. Lung Cancer 40:247-58, 2003.
34. Lin P, Hsueh YM, Ko JL, Liang YF, Tsai KJ, Chen CY:. Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan. Lung Cancer 40:123-129, 2003.
35. Stucker I, Hirvonen A, de Waziers I, Cabelguenne A, Mitrunen K, Cenee S. Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility. Carcinogenesis. 23:1475-81, 2002.
36. To-Figueras J, Gene M, Gomez-Catalan J, Pique E, Borrego N, Corbella J. Lung cancer susceptibility in relation to combined polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1. Cancer Lett 173:155-162, 2001.
37. Saarikoski ST, Voho A, Reinikainen M, Anttila S, Karjalainen A, Malaveille C. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer 77:516-521, 1998.
38. Chen HC, Cao YF, Hu WX, Liu XF, Liu QX, Zhang J. Genetic polymorphisms of phase II metabolic enzymes and lung cancer susceptibility in a population of Central South China. Dis Markers.22:141-52, 2006.
39. Kiyohara C, Yamamura KI, Nakanishi Y, Takayama K, Hara N: Polymorphism in GSTM1, GSTT1, and GSTP1 and Susceptibility to Lung Cancer in a Japanese Population. Asian Pac J Cancer Prev 1:293-298, 2000.
40. Salagovic J, Kalina I, Stubna J, Habalova V, Hrivnak M, Valansky L. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers. Neoplasma 45:312-317, 1998.
41. Deakin M, Elder J, Hendrickse C, Peckham D, Baldwin D, Pantin C. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis 17:881-884, 1996.
42. To-Figueras J, Gene M, Gomez-Catalan J, Galan MC, Fuentes M, Ramon JM. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterraneans.Carcinogenesis 18:1529-33, 1997.
43. Kelsey KT, Nelson HH, Wiencke JK, Smith CM, Levin S. The glutathione S-transferase theta and mu deletion polymorphisms in asbestosis. Am J Ind Med 31:274-9, 1997.
44. Jourenkova N, Reinikanen M, Bouchardy C, Husgafvel-Pursiainen K, Dayer P, Benhamou S. Effects of glutathione S-transferases GSTM1 and GSTT1 genotypes on lung cancer risk in smokers. Pharmacogenetics 7:515-518, 1997.
45. Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, et al. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 18:1285-1289, 1997.
46. Kihara M, Kihara M, Noda K. Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis 15:415-418, 1994.
47. Wang J, Deng Y, Cheng J, Ding J, Tokudome S: GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett 201:185-193, 2003.
48. Mollerup S, Ryberg D, Skaug V, Haugen A. Lung cancer susceptibility. Norsk Epidmiol 12:137-43, 2002.
49. Reszka E, Wasowicz W, Rydzynski K, Szeszenia-Dabrowska N, Szymczak W: Glutathione S-transferase M1 and P1 metabolic polymorphism and lung cancer predisposition. Neoplasma 50:357-362, 2003.
50. To-Figueras J, Gene M, Gomez-Catalan J, Pique E, Borrego N, Carrasco JL. Genetic polymorphism of glutathione S-transferase P1 gene and lung cancer risk. Cancer Causes Control 10:65-70, 1999.
51. Spitz,M.R., Duphorne,C.M., Detry,M.A., Pillow,P.C., Amos,C.I., Lei,L., de Andrade,M., Gu,X., Hong,W.K. and Wu,X. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol. Biomarkers Prev 9: 1017-1020, 2000.
52. Sorensen,M., Autrup,H., Tjonneland,A., Overvad,K. and Raaschou-Nielsen,O. Glutathione S-transferase T1 null-genotype is associated with an increased risk of lung cancer. Int J Cancer 110:219-224, 2004.
53. Hou SM, Fält S, Nyberg F. Glutathione S-transferase T1-null genotype interacts synergistically with heavy smoking on lung cancer risk. Environmental and Molecular Mutagenesis 38: 83-86, 2001.
54. Raimondi S, Boffetta P, Anttila S, Bröckmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Dragani TA, Garte S, Gsur A, Haidinger G, Hirvonen A, Ingelman-Sundberg M, Kalina I, Lan Q, Leoni VP, Le Marchand L, London SJ, Neri M, Povey AC, Rannug A, Reszka E, Ryberg D, Risch A, Romkes M, Ruano-Ravina A, Schoket B, Spinola M, Sugimura H, Wu X, Taioli E. Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study. Mutat Res 592:45-57, 2005.
55. Chan-Yeung M, Tan-Un KC, Ip MS, Tsang KW, Ho SP, Ho JC, Chan H, Lam WK. Lung cancer susceptibility and polymorphisms of glutathione-S-transferase genes in Hong Kong. Lung Cancer 45:155-60, 2004.
56. Miller,D.P., De Vivo,I., Neuberg,D., Wain,J.C., Lynch,T.J., Su,L. and Christiani,D.C. (2003) Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism. Int. J. Cancer, 104, 758-763.
57. Hayes JD, Strange RC: Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61:154-166, 2000.
58. Sweeney C, Nazar-Stewart V, Stapleton PL, Eaton DL, Vaughan TL: Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients. Cancer Epidemiol Biomarkers Prev 12:527-533, 2003.
59. Gonlugur U, Pinarbasi H, Gonlugur TE, Silig Y. The association between polymorphisms in glutathione S-transferase (GSTM1 and GSTT1) and lung cancer outcome. Cancer Invest 24:497-501, 2006.
60. Lu C, Spitz MR, Zhao H, Dong Q, Truong M, Chang JY. Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma. Cancer 106:441-447, 2006.
61. Howells R E, Redman CW, Dhar KK, Sarhanis P, Musgrove C, Jones PW, Alldersea J, Fryer AA, Hoban PR, Strange RC. Association of glutathione S-transferase GSTM1 and GSTT1 null genotypes with clinical outcome in epithelial ovarian cancer. Clin. Cancer Res 4: 2439-2445, 1998.